These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1415534)

  • 21. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs.
    Shiota M; Jackson PA; Bischoff H; McCaleb M; Scott M; Monohan M; Neal DW; Cherrington AD
    Am J Physiol; 1997 Nov; 273(5):E868-79. PubMed ID: 9374671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog.
    Gustavson SM; Chu CA; Nishizawa M; Farmer B; Neal D; Yang Y; Donahue EP; Flakoll P; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E695-707. PubMed ID: 12626324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of insulin on glucagon-stimulated glucose production in the conscious dog.
    Steiner KE; Williams PE; Lacy WW; Cherrington AD
    Metabolism; 1990 Dec; 39(12):1325-33. PubMed ID: 2246975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog.
    McGuinness OP; Fugiwara T; Murrell S; Bracy D; Neal D; O'Connor D; Cherrington AD
    Am J Physiol; 1993 Aug; 265(2 Pt 1):E314-22. PubMed ID: 8368302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperglucagonemia and hepatic glucose metabolism during infection in the conscious dog.
    McGuinness OP; Lacy DB; Eliasson K
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E580-8. PubMed ID: 8928762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered ability of the liver to produce glucose following a period of glucagon deficiency.
    Deri JJ; Williams PE; Steiner KE; Cherrington AD
    Diabetes; 1981 Jun; 30(6):490-5. PubMed ID: 6112181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
    Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
    J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Jennings AS; Keller U; Lacy WW
    J Clin Invest; 1976 Dec; 58(6):1407-18. PubMed ID: 993351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism.
    Goldstein RE; Wasserman DH; McGuinness OP; Lacy DB; Cherrington AD; Abumrad NN
    Am J Physiol; 1993 Jan; 264(1 Pt 1):E119-27. PubMed ID: 8430780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Net hepatic gluconeogenic amino acid uptake in response to peripheral versus portal amino acid infusion in conscious dogs.
    Moore MC; Hsieh PS; Flakoll PJ; Neal DW; Cherrington AD
    J Nutr; 1999 Dec; 129(12):2218-24. PubMed ID: 10573553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic alpha- and beta-adrenergic receptors are not essential for the increase in R(a) during exercise in diabetes.
    Coker RH; Lacy DB; Williams PE; Wasserman DH
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E444-51. PubMed ID: 10710498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog.
    Cherrington AD; Lacy WW; Williams PE; Steiner KE
    Am J Physiol; 1983 Jun; 244(6):E596-602. PubMed ID: 6134474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion.
    McGuinness OP; Ejiofor J; Audoly LP; Schrom N
    Am J Physiol; 1998 Sep; 275(3):E432-9. PubMed ID: 9725809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of glucagon on glucose production during insulin deficiency in the dog.
    Cherrington AD; Lacy WW; Chiasson JL
    J Clin Invest; 1978 Sep; 62(3):664-77. PubMed ID: 690190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Portal adrenergic blockade does not inhibit the gluconeogenic effects of circulating catecholamines on the liver.
    Chu CA; Sindelar DK; Neal DW; Cherrington AD
    Metabolism; 1997 Apr; 46(4):458-65. PubMed ID: 9109855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.
    Flattem N; Igawa K; Shiota M; Emshwiller MG; Neal DW; Cherrington AD
    Diabetes; 2001 Feb; 50(2):367-75. PubMed ID: 11272149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of stable metabolic conditions during islet suppression in dogs.
    Bradley DC; Bergman RN
    Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.